{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:56:27Z","timestamp":1788472587143,"version":"build-2803163510"},"reference-count":78,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII)","doi-asserted-by":"publisher","award":["PI22\/00404"],"award-info":[{"award-number":["PI22\/00404"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III (ISCIII)","doi-asserted-by":"publisher","award":["FI23\/00090"],"award-info":[{"award-number":["FI23\/00090"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PFIS 2023","award":["PI22\/00404"],"award-info":[{"award-number":["PI22\/00404"]}]},{"name":"PFIS 2023","award":["FI23\/00090"],"award-info":[{"award-number":["FI23\/00090"]}]},{"name":"FSE+","award":["PI22\/00404"],"award-info":[{"award-number":["PI22\/00404"]}]},{"name":"FSE+","award":["FI23\/00090"],"award-info":[{"award-number":["FI23\/00090"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>With ever-increasing incidence and high metastatic potential, cutaneous melanoma is the deadliest skin cancer. Risk prediction based on the Tumor-Node-Metastasis (TNM) staging system has medium accuracy with intermediate IIB-IIIB stages, as roughly 25% of patients with low-medium-grade TNM, and hence a favorable prognostic, undergo an aggressive disease with short survival and around 15% of deaths arise from metastases of thin, low-risk lesions. Therefore, reliable prognostic biomarkers are required. We used genomic and clinical information of melanoma patients from the TCGA-SKCM cohort and two GEO studies for discovery and validation of potential biomarkers, respectively. Neither mutation nor overexpression of major melanoma driver genes provided significant prognostic information. Conversely, expression of MGRN1 and the melanocyte-specific genes MLANA, PMEL, and TYRP1 provided a simple 4-gene signature identifying with high-sensitivity (&gt;80%), low-medium TNM patients with adverse outcomes. Transcriptomic analysis of tumors with this signature, or from low-medium-grade TNM patients with poor outcomes, revealed comparable dysregulation of an inflammatory response, cell cycle progression, and DNA damage\/repair programs. A functional analysis of MGRN1-knockout cells confirmed these molecular features. Therefore, the simple MGRN1-MLANA-PMEL-TYRP1 combination of biomarkers complemented TNM staging prognostic accuracy and pointed to the dysregulation of immunological responses and genomic stability as determinants of a melanoma outcome.<\/jats:p>","DOI":"10.3390\/ijms26041739","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T06:41:12Z","timestamp":1739860872000},"page":"1739","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An MGRN1-Based Biomarker Combination Accurately Predicts Melanoma Patient Survival"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9585-1817","authenticated-orcid":false,"given":"Jos\u00e9","family":"S\u00e1nchez-Beltr\u00e1n","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, Campus de Excelencia Internacional Regional (CEIR), Campus Mare Nostrum (CMN), University of Murcia, 30120 Murcia, Spain"},{"name":"Biomedical Research Institute of Murcia (Instituto Murciano de Investigaci\u00f3n Biosanitaria, IMIB), 30120 Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9567-7474","authenticated-orcid":false,"given":"Javier","family":"Soler D\u00edaz","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, Campus de Excelencia Internacional Regional (CEIR), Campus Mare Nostrum (CMN), University of Murcia, 30120 Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Herraiz","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, Campus de Excelencia Internacional Regional (CEIR), Campus Mare Nostrum (CMN), University of Murcia, 30120 Murcia, Spain"},{"name":"Biomedical Research Institute of Murcia (Instituto Murciano de Investigaci\u00f3n Biosanitaria, IMIB), 30120 Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7518-3858","authenticated-orcid":false,"given":"Conchi","family":"Olivares","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, Campus de Excelencia Internacional Regional (CEIR), Campus Mare Nostrum (CMN), University of Murcia, 30120 Murcia, Spain"},{"name":"Biomedical Research Institute of Murcia (Instituto Murciano de Investigaci\u00f3n Biosanitaria, IMIB), 30120 Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Cerdido","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, Campus de Excelencia Internacional Regional (CEIR), Campus Mare Nostrum (CMN), University of Murcia, 30120 Murcia, Spain"},{"name":"Biomedical Research Institute of Murcia (Instituto Murciano de Investigaci\u00f3n Biosanitaria, IMIB), 30120 Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4886-4831","authenticated-orcid":false,"given":"Pablo","family":"Cerezuela-Fuentes","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute of Murcia (Instituto Murciano de Investigaci\u00f3n Biosanitaria, IMIB), 30120 Murcia, Spain"},{"name":"Medical Oncology Department, Hospital Cl\u00ednico Universitario Virgen de La Arrixaca, 30120 Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9192-588X","authenticated-orcid":false,"given":"Jos\u00e9 Carlos","family":"Garc\u00eda-Borr\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, Campus de Excelencia Internacional Regional (CEIR), Campus Mare Nostrum (CMN), University of Murcia, 30120 Murcia, Spain"},{"name":"Biomedical Research Institute of Murcia (Instituto Murciano de Investigaci\u00f3n Biosanitaria, IMIB), 30120 Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5821-9510","authenticated-orcid":false,"given":"Celia","family":"Jim\u00e9nez-Cervantes","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, Campus de Excelencia Internacional Regional (CEIR), Campus Mare Nostrum (CMN), University of Murcia, 30120 Murcia, Spain"},{"name":"Biomedical Research Institute of Murcia (Instituto Murciano de Investigaci\u00f3n Biosanitaria, IMIB), 30120 Murcia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous Melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/ijc.31527","article-title":"Global Burden of Cutaneous Melanoma Attributable to Ultraviolet Radiation in 2012","volume":"143","author":"Arnold","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 Human Cancer Genomes Reveals the Landscape of Tumor Mutational Burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Marquard, A.M., Eklund, A.C., Joshi, T., Krzystanek, M., Favero, F., Wang, Z.C., Richardson, A.L., Silver, D.P., Szallasi, Z., and Birkbak, N.J. (2015). Pan-Cancer Analysis of Genomic Scar Signatures Associated with Homologous Recombination Deficiency Suggests Novel Indications for Existing Cancer Drugs. Biomark. Res., 3.","DOI":"10.1186\/s40364-015-0033-4"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41591-023-02682-0","article-title":"Insights for Precision Oncology from the Integration of Genomic and Clinical Data of 13,880 Tumors from the 100,000 Genomes Cancer Programme","volume":"30","author":"Sosinsky","year":"2024","journal-title":"Nat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s12967-022-03670-7","article-title":"Analysis of Gene Expression Levels and Their Impact on Survival in 31 Cancer-Types Patients Identifies Novel Prognostic Markers and Suggests Unexplored Immunotherapy Treatment Options in a Wide Range of Malignancies","volume":"20","author":"Giampietri","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The Immune Landscape of Cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Li, M., Gao, X., and Wang, X. (2023). Identification of Tumor Mutation Burden-Associated Molecular and Clinical Features in Cancer by Analyzing Multi-Omics Data. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1090838"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/jdv.15302","article-title":"Increased Tumour Cell PD-L1 Expression, Macrophage and Dendritic Cell Infiltration Characterise the Tumour Microenvironment of Ulcerated Primary Melanomas","volume":"33","author":"Koelblinger","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic Correlates of Response to CTLA-4 Blockade in Metastatic Melanoma","volume":"350","author":"Miao","year":"2015","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic Classification of Cutaneous Melanoma","volume":"161","author":"Akbani","year":"2015","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-Genome Landscapes of Major Melanoma Subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.3361","article-title":"Exome Sequencing Identifies Recurrent Mutations in NF1 and RASopathy Genes in Sun-Exposed Melanomas","volume":"47","author":"Krauthammer","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A Landscape of Driver Mutations in Melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"T\u00edm\u00e1r, J., and Lad\u00e1nyi, A. (2022). Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105384"},{"key":"ref_18","first-page":"13","article-title":"Diagnostic and Prognostic Biomarkers in Melanoma","volume":"7","author":"Weinstein","year":"2014","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/CJI.0000000000000374","article-title":"PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM)","volume":"44","author":"Zhang","year":"2021","journal-title":"J. Immunother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"110569","DOI":"10.1016\/j.celrep.2022.110569","article-title":"Genome-Wide Identification and Analysis of Prognostic Features in Human Cancers","volume":"38","author":"Smith","year":"2022","journal-title":"Cell Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma Staging: Evidence-based Changes in the American Joint Committee on Cancer Eighth Edition Cancer Staging Manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e006947","DOI":"10.1136\/jitc-2023-006947","article-title":"Society for Immunotherapy of Cancer (SITC) Clinical Practice Guideline on Immunotherapy for the Treatment of Melanoma, Version 3.0","volume":"11","author":"Pavlick","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e2245269","DOI":"10.1001\/jamanetworkopen.2022.45269","article-title":"Melanoma Treatments and Mortality Rate Trends in the US, 1975 to 2019","volume":"5","author":"Kahlon","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1200\/JCO.2006.08.1463","article-title":"Identification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas","volume":"25","author":"Gimotty","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1007\/s12094-024-03501-9","article-title":"Access to Melanoma Drugs in Spain: A Cross-Sectional Survey","volume":"26","author":"Puertolas","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jdv.13940","article-title":"Melanoma Antigens Are Biomarkers for Ipilimumab Response","volume":"31","author":"Arenberger","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/jdv.16766","article-title":"The Predictive and Prognostic Significance of Cell-free DNA Concentration in Melanoma","volume":"35","author":"Elouali","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Dixon, A.J., Steinman, H.K., Nirenberg, A., Zouboulis, C.C., Sladden, M., Popescu, C., Anderson, S., Longo, C., and Thomas, J.M. (2024). BAUSSS Biomarker Improves Melanoma Survival Risk Assessment. J. Eur. Acad. Dermatol. Venereol.","DOI":"10.1111\/jdv.20292"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/DAD.0000000000002863","article-title":"The Utility of PRAME and Ki-67 as Prognostic Markers for Cutaneous Melanoma","volume":"47","author":"Asato","year":"2025","journal-title":"Am. J. Dermatopathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jnci\/djp038","article-title":"Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-Analysis","volume":"101","author":"Rothberg","year":"2009","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jnci\/djj103","article-title":"Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome","volume":"98","author":"Winnepenninckx","year":"2006","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41467-021-21207-2","article-title":"Tumour Gene Expression Signature in Primary Melanoma Predicts Long-Term Outcomes","volume":"12","author":"Garg","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"31714","DOI":"10.1074\/jbc.M109.028100","article-title":"Mahogunin Ring Finger-1 (MGRN1) E3 Ubiquitin Ligase Inhibits Signaling from Melanocortin Receptor by Competition with Galphas","volume":"284","author":"Olivares","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.bbadis.2017.02.027","article-title":"MC1R Signaling. Intracellular Partners and Pathophysiological Implications","volume":"1863","author":"Herraiz","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.semcdb.2013.03.014","article-title":"Pleiotropic Effects of Coat Colour-Associated Mutations in Humans, Mice and Other Mammals","volume":"24","author":"Reissmann","year":"2013","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00018-021-04053-9","article-title":"Mahogunin Ring Finger 1 Regulates Pigmentation by Controlling the PH of Melanosomes in Melanocytes and Melanoma Cells","volume":"79","author":"Lambertos","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Abrisqueta, M., Cerdido, S., S\u00e1nchez-Beltr\u00e1n, J., Mart\u00ednez-Vicente, I., Herraiz, C., Lambertos, A., Olivares, C., Sevilla, A., Alonso, S., and Boyano, M.D. (2022). MGRN1 as a Phenotypic Determinant of Human Melanoma Cells and a Potential Biomarker. Life, 12.","DOI":"10.3390\/life12081118"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"216484","DOI":"10.1016\/j.canlet.2023.216484","article-title":"MGRN1 Depletion Promotes Intercellular Adhesion in Melanoma by Upregulation of E-Cadherin and Inhibition of CDC42","volume":"581","author":"Cerdido","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Vicente, I., Abrisqueta, M., Herraiz, C., Sir\u00e9s-Campos, J., Castej\u00f3n-Gri\u00f1\u00e1n, M., Bennett, D.C., Olivares, C., Garc\u00eda-Borr\u00f3n, J.C., and Jim\u00e9nez-Cervantes, C. (2020). Mahogunin Ring Finger 1 Is Required for Genomic Stability and Modulates the Malignant Phenotype of Melanoma Cells. Cancers, 12.","DOI":"10.3390\/cancers12102840"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer Analysis Project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene Set Enrichment Analysis: A Knowledge-Based Approach for Interpreting Genome-Wide Expression Profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/bjc.2013.115","article-title":"Tyrosinase-Related Protein 1 MRNA Expression in Lymph Node Metastases Predicts Overall Survival in High-Risk Melanoma Patients","volume":"108","author":"Journe","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41568-023-00565-7","article-title":"The Journey from Melanocytes to Melanoma","volume":"23","author":"Centeno","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/pcmr.12257","article-title":"MC1R, the cAMP Pathway, and the Response to Solar UV: Extending the Horizon beyond Pigmentation","volume":"27","year":"2014","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0002-9440(10)63657-7","article-title":"MLANA\/MART1 and SILV\/PMEL17\/GP100 Are Transcriptionally Regulated by MITF in Melanocytes and Melanoma","volume":"163","author":"Du","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"20429","DOI":"10.1073\/pnas.0905139106","article-title":"Immune Profile and Mitotic Index of Metastatic Melanoma Lesions Enhance Clinical Staging in Predicting Patient Survival","volume":"106","author":"Bogunovic","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"12297","DOI":"10.18632\/oncotarget.3655","article-title":"Molecular Stratification of Metastatic Melanoma Using Gene Expression Profiling: Prediction of Survival Outcome and Benefit from Molecular Targeted Therapy","volume":"6","author":"Cirenajwis","year":"2015","journal-title":"Oncotarget"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"R246","DOI":"10.1016\/j.cub.2020.01.031","article-title":"Tumor-Associated Macrophages","volume":"30","author":"Cassetta","year":"2020","journal-title":"Curr. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-Associated Macrophages: From Mechanisms to Therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e000337","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus Guidelines for the Definition, Detection and Interpretation of Immunogenic Cell Death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Kang, K., Xie, F., Mao, J., Bai, Y., and Wang, X. (2020). Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.573141"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","article-title":"Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers","volume":"16","author":"Goodman","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9440(10)63110-0","article-title":"Progression in Cutaneous Malignant Melanoma Is Associated with Distinct Expression Profiles","volume":"164","author":"Alonso","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1158\/1078-0432.CCR-09-1777","article-title":"A Multimarker Prognostic Assay for Primary Cutaneous Melanoma","volume":"15","author":"Venna","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/modpathol.2012.32","article-title":"Differential Gene Expression Profiling of Primary Cutaneous Melanoma and Sentinel Lymph Node Metastases","volume":"25","author":"Koh","year":"2012","journal-title":"Mod. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1479-5876-4-50","article-title":"A Gene Expression Signature Associated with Survival in Metastatic Melanoma","volume":"4","author":"Mandruzzato","year":"2006","journal-title":"J. Transl. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1158\/1541-7786.MCR-07-0344","article-title":"Gene Expression Changes in an Animal Melanoma Model Correlate with Aggressiveness of Human Melanoma Metastases","volume":"6","author":"Xu","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41586-023-06054-z","article-title":"Pan-Cancer Whole-Genome Comparison of Primary and Metastatic Solid Tumours","volume":"618","author":"Movasati","year":"2023","journal-title":"Nature"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-Cancer Analysis of Whole Genomes","volume":"578","author":"Aaltonen","year":"2020","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00432-024-05957-2","article-title":"Melanoma Genomics\u2013Will We Go beyond BRAF in Clinics?","volume":"150","author":"Mirek","year":"2024","journal-title":"J Cancer Res. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/pcmr.12067","article-title":"PMEL: A Pigment Cell-specific Model for Functional Amyloid Formation","volume":"26","author":"Watt","year":"2013","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00262-015-1664-x","article-title":"Broadening the Repertoire of Melanoma-Associated T-Cell Epitopes","volume":"64","author":"Lyngaa","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1101\/gad.324657.119","article-title":"MITF\u2014The First 25 Years","volume":"33","author":"Goding","year":"2019","journal-title":"Genes Dev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1101\/gad.406406","article-title":"Mitf Regulation of Dia1 Controls Melanoma Proliferation and Invasiveness","volume":"20","author":"Carreira","year":"2006","journal-title":"Genes Dev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1101\/gad.329771.119","article-title":"Melanoma Plasticity and Phenotypic Diversity: Therapeutic Barriers and Opportunities","volume":"33","author":"Rambow","year":"2019","journal-title":"Genes Dev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41568-019-0154-4","article-title":"Phenotype Plasticity as Enabler of Melanoma Progression and Therapy Resistance","volume":"19","author":"Arozarena","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Slominski, R.M., Sarna, T., P\u0142onka, P.M., Raman, C., Bro\u017cyna, A.A., and Slominski, A.T. (2022). Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.842496"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/bjc.2011.451","article-title":"TYRP1 MRNA Expression in Melanoma Metastases Correlates with Clinical Outcome","volume":"105","author":"Journe","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/ncb3623","article-title":"A Non-Coding Function of TYRP1 MRNA Promotes Melanoma Growth","volume":"19","author":"Gilot","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/1078-0432.CCR-23-3932","article-title":"Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma","volume":"30","author":"Aung","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.annonc.2024.03.007","article-title":"Tumor Mutational Burden for the Prediction of PD-(L)1 Blockade Efficacy in Cancer: Challenges and Opportunities","volume":"35","author":"Wang","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jmoldx.2024.05.002","article-title":"Recommendations for Tumor Mutational Burden Assay Validation and Reporting","volume":"26","author":"Furtado","year":"2024","journal-title":"J. Mol. Diagn."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Love, M.I., Huber, W., and Anders, S. (2014). Moderated Estimation of Fold Change and Dispersion for RNA-Seq Data with DESeq2. Genome Biol., 15.","DOI":"10.1186\/s13059-014-0550-8"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database Hallmark Gene Set Collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular Signatures Database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: A Web Server for Cancer and Normal Gene Expression Profiling and Interactive Analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: A Bridge between the Gene Expression Omnibus (GEO) and BioConductor","volume":"23","author":"Davis","year":"2007","journal-title":"Bioinformatics"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"Affy\u2014Analysis of Affymetrix GeneChip Data at the Probe Level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinformatics"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/4\/1739\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:36:56Z","timestamp":1760027816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/4\/1739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":78,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["ijms26041739"],"URL":"https:\/\/doi.org\/10.3390\/ijms26041739","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]}}}